Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR)

Choueiri, TK; Zakharia, Y; Pal, S; Kocsis, J; Pachynski, R; Poprach, A; Nixon, AB; Liu, YM; Starr, M; Lyu, J; Owzar, K; DeShazo, M; Lara, P; Geczi, L; Ho, TH; Walsh, M; Adams, B; Robertson, L; Darif, M; Theuer, C; Agarwal, N

Choueiri, TK (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA.

ONCOLOGIST, 2021; 26 (7): 560

Abstract

Lessons Learned The combination of carotuximab with axitinib did not provide a benefit over axitinib monotherapy in patients with metastatic clear cel......

Full Text Link